Ashna Fathima

Ms. Ashna Fathima

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YOGESH MAHADU KHETMALISYOGESH MAHADU KHETMALIS
YOGESH MAHADU KHETMALIS
AFAshna Fathima
Ashna Fathima
MSMarkus Schweipert
Markus Schweipert
CDCécile Debarnot
Cécile Debarnot
NBNaga Venkata Madhusudhan Rao Bandaru
Naga Venkata Madhusudhan Rao Bandaru
KSKondapalli Venkata Gowri Chandra Sekhar
Kondapalli Venkata Gowri Chandra Sekhar
A series of novel quinazoline-4-(3H)-one derivatives were designed and synthesized as histone deacetylase 6 (HDAC6) inhibitors based on novel quinazoline-4-(3H)-one as the cap group and benzhydroxamic acid as the linker and metal-binding group. A total of 19 novel quinazoline-4-(3H)-one analogues (5a–5s) were obtained. The structures of the target compounds were characterized using 1H-NMR, 13C-NMR, LC–MS, and elemental analyses. Characterized compounds were screened for inhibition against HDAC8 class I, HDAC4 class IIa, and HDAC6 class IIb. Among the compounds tested, 5b proved to be the most potent and selective inhibitor of HDAC6 with an IC50 value 150 nM. Some of these compounds showed potent antiproliferative activity in several tumor cell lines (HCT116, MCF7, and B16). Amongst all the compounds tested for their anticancer effect against cancer cell lines, 5c emerged to be most active against the MCF-7 line with an IC50 of 13.7 μM; it exhibited cell-cycle arrest in the G2 phase, as well as promoted apoptosis. Additionally, we noted a significant reduction in the colony-forming capability of cancer cells in the presence of 5c. At the intracellular level, selective inhibition of HDAC6 was enumerated by monitoring the acetylation of α-tubulin with a limited effect on acetyl-H3. Importantly, the obtained results suggested a potent effect of 5c at sub-micromolar concentrations as compared to the other molecules as HDAC6 inhibitors in vitro.

11 January 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
YKYogesh Mahadu Khetmalis
Yogesh Mahadu Khetmalis
BSBakhya Shree
Bakhya Shree
BKBoddupalli Venkata Siva Kumar
Boddupalli Venkata Siva Kumar
MSMarkus Schweipert
Markus Schweipert
CDCécile Debarnot
Cécile Debarnot
KSKondapalli Venkata Gowri Chandra Sekhar
Kondapalli Venkata Gowri Chandra Sekhar

1 March 2025 in European Journal of Medicinal Chemistry Reports
Verified
Journal Article
Open access
NBN.V.M. Rao Bandaru
N.V.M. Rao Bandaru
AFAshna Fathima
Ashna Fathima
VJVandana Joshi
Vandana Joshi
MSMarkus Schweipert
Markus Schweipert
OPObanna Pathur
Obanna Pathur
KSKondapalli Venkata Gowri Chandra Sekhar
Kondapalli Venkata Gowri Chandra Sekhar